Gyre Therapeutics
GYRE
$11.93
Share price
20.63%
Change (1 day)
133.92%
Change (1 year)
Categories
Gyre Therapeutics (GYRE) - Cash on Hand
Cash on Hand as of March 2024 : $37.35 M
According to Gyre Therapeutics's latest financial reports the company has $37.35 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Gyre Therapeutics - Cash on Hand chart (from 2024 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $33.5 M | 818.01% |
| 2022-12-31 | $3.65 M | -12.16% |
| 2021-12-31 | $4.15 M |